Inhibition of Topoisomerases by Antitumor Prostaglandins. | Zendy

Keitarou Suzuki | Zendy; Fumiko Shono | Zendy; Masaru Uyeda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Inhibition of Topoisomerases by Antitumor Prostaglandins.

Author(s) -

Keitarou Suzuki,

Fumiko Shono,

Masaru Uyeda

Publication year - 1998

Publication title -

bioscience biotechnology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.509

H-Index - 116

eISSN - 1347-6947

pISSN - 0916-8451

DOI - 10.1271/bbb.62.2073

Subject(s) - topoisomerase , ic50 , prostaglandin , chemistry , pharmacology , enzyme , biology , biochemistry , in vitro

Topoisomerase II from human placenta was strongly inhibited by prostaglandins such as delta 12,14-PGJ2, delta 12-PGJ2, PGA2, and PGA1, which have an antitumor activity. The topoisomerase II inhibitions by these prostaglandins were dose-dependent and IC50 values of delta 12,14-PGJ2, delta 12-PGJ2, PGA2, and PGA1 were 22 microM, 74 microM, 75 microM, and 98 microM, respectively. Topoisomerase I from calf thymus gland was inhibited by delta 12,14-PGJ2, delta 12-PGJ2, and PGA2, but not inhibited by other prostaglandins even at high concentrations. Only the prostaglandins having the antitumor activity inhibited topoisomerase II. The results suggest that the antitumor activity of prostaglandins may be related, at least in part, to inhibition of topoisomerase II in tumor cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research